Physician profile
Steven Mazzone
NPI 1467982181
$1,527.35
in general payments reported to CMS, 2019-2025
18 companies · $22.11 in 2025
The $22.11 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $341 · 2021: $300 · 2022: $419 · 2023: $422 · 2024: $23.29 · 2025: $22.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $315.85 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $293.13 | 2020-2023 | Brilinta |
| Janssen Pharmaceuticals, INC | $157.39 | 2020-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.66 | 2020-2023 | Lifevest |
| Lantheus Medical Imaging, INC. | $109.53 | 2020-2023 | Definity |
| Amgen INC. | $85.81 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $73.86 | 2023-2025 | |
| Cardiva Medical, INC. | $61.40 | 2023 | Cardiva Vascade 6/7f Vcs |
| Abbott Laboratories | $58.22 | 2021-2023 | Amplatzer Amulet |
| Cardiovascular Systems INC. | $36.30 | 2021 | |
| Zoll Circulation INC | $35.32 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $34.90 | 2022-2023 | Camzyos |
| Abiomed | $28.06 | 2020 | |
| Boston Scientific Corporation | $27.99 | 2020 | |
| Edwards Lifesciences Corporation | $25.23 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $23.62 | 2022 | |
| Novo Nordisk INC | $23.29 | 2024 | Ozempic |
| Terumo Medical Corporation | $17.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mazzone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.